Roche sued by British rival
A United States unit of GlaxoSmithKline (GSK), Britain’s largest drugmaker, is suing Swiss rival Roche for infringing a patent.
According to GlaxoSmithKline, Roche Holding infringes patents issued in 2008 and 2010 covering antibody purification when it produces its cancer drug Herceptin.
Roche, and its United States business Genentech, infringe the patent by “making and/or having made therapeutic antibody products, including without limitation Herceptin,” the complaint said.
Glaxo is demanding damages to compensate for violations of its patent.
Genentech declined to comment except to say that it was aware of the lawsuit and that a second lawsuit had been filed in the Northern District of California. The California lawsuit was brought by Genentech against Glaxo, according to Caroline Pecquet, a Genentech spokeswoman.
More
New rail links planned from Switzerland to London
More
The American who quit art to discover the odd side of Switzerland
More
Face time: the terrifying Swiss tradition of Tschäggättä
More
Switzerland’s global image got a boost in 2024
More
Explainer: Why US health funding cuts are rattling Swiss science
In compliance with the JTI standards
More: SWI swissinfo.ch certified by the Journalism Trust Initiative
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.